This is a preview of subscription content, log in via an institution to check access.
Data Availability
No datasets were generated or analysed during the current study.
References
Joshi AY, Ham EK, Shah NB, Dong X, Khan SP, Abraham RS. Atypical Omenn syndrome due to Adenosine Deaminase Deficiency. Case Rep Immunol. 2012;2012:1–4.
Roifman CM, Zhang J, Atkinson A, Grunebaum E, Mandel K. Adenosine deaminase deficiency can present with features of Omenn syndrome. J Allergy Clin Immunol. 2008;121(4):1056–8.
Reid W, Jyonouchi S, Bunin N, Heimall J. Treatment of Omenn syndrome using multiple immunosuppressive strategies: a case series. Clin Immunol. 2023;250:109596.
Malacarne F, Benicchi T, Notarangelo LD, Mori L, Parolini S, Caimi L, et al. Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients. Eur J Immunol. 2005;35(11):3376–86.
Migliavacca M, Barzaghi F, Fossati C, Rancoita PMV, Gabaldo M, Dionisio F, et al. Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency. Nat Med. 2024;30(2):488–97.
Acknowledgements
We would like to acknowledge the family for providing written informed consent for publication of this case report including the images.
Funding
The authors declare no conflicts of interest or sources of funding.
Author information
Authors and Affiliations
Contributions
E.F wrote the main manuscript text and prepared the figures and tables. P.M. reviewed the manuscript and contributed clinical details. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Ethics approval
This case report was reviewed and endorsed by the Children’s Health Queensland Hospital and Health service Human Research Ethics Committee.
Informed consent
Written informed consent was obtained from the parents, including consent to publish the image in Figure S1a.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Forbes, E.M., McNaughton, P.B. Omenn Syndrome can Occur during Enzyme Therapy for Adenosine Deaminase Deficiency. J Clin Immunol 44, 162 (2024). https://doi.org/10.1007/s10875-024-01764-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10875-024-01764-z